Spotlight

Dr Celia Caulcott appointed Vice-Provost (Enterprise)

Dr Celia Caulcott has been appointed the next Vice-Provost (Enterprise) at UCL, with effect from 1 October 2015.

The Office of the Vice-Provost (Enterprise) is responsible for delivering UCL’s Enterprise agenda with the greatest economic and societal impact. Vice-Provosts are members of the Provost's senior management team. 

Read the full article



follow us on twitter


Archive of News

<< 2013 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2015 >>

28 May 2014: Blood vessel research offers insights into new treatments for eye diseases

Leukaemia drugs could help to improve treatments for blindness caused by abnormal blood vessel growth in the eye, finds new UCL research. More...

22 May 2014: UCL launches ‘The Games Quarter’, a new model for CPD in the videogame industry

UCL, in partnership with TIGA is launching a new model of continuing professional development for the videogame industry, with its course The Games Quarter. More...

21 May 2014: UCL, Imperial & Cell Therapy Catapult collaborate to advance leukaemia cell therapy

A novel cell therapy approach to the treatment of acute myeloid leukaemia is to be developed further via an innovative partnership between the Cell Therapy Catapult, which is focused on the development of the UK cell therapy industry to increase the nation’s health and wealth, UCL Business (UCLB) and Imperial Innovations. More...

14 May 2014: Novozymes Biopharma to offer drug-albumin conjugation platform in collaboration with UCLB spinout ThioLogics

ThioLogics, a UCL Business company, spun-out of the UCL Department of Chemistry has entered into a new collaboration with Novozymes Biopharma.
More...

<< 2013 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2015 >>